A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab Emtansine
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Pregnancy
Interventions: DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Ado-Trastuzumab Emtansine
Sponsor: Genentech, Inc.